Figure 3From: Multipotent adult progenitor cells decrease cold ischemic injury in ex vivo perfused human lungs: an initial pilot and feasibility studySemi-quantitative scoring demonstrates significant decrease in overall inflammation in the MAPC-treated LLL compared to the vehicle-treated RLL in three out of four lungs and in aggregate. Means ± SD of pooled observations from three blinded observers are depicted.Back to article page